5 Recruiting Studies Using Bi 764532
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Bi 764532
π΅ Active, Not Recruiting Phase1 π Investigational Drug / Biologic
DAREONβ’-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine Cancers
π University of Miami β Miami, Florida
Neuroendocrine Neoplasms
View Study & Checklist β π΅ Active, Not Recruiting Phase1 π Investigational Drug / Biologic
DAREONβ’-9: A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With Small Cell Lung Cancer When Taken Together With a Single Agent Chemotherapy
π MedStar Georgetown University Hospital β Washington D.C., District of Columbia
Small Cell Lung Carcinoma (SCLC)
View Study & Checklist β π΅ Active, Not Recruiting Phase1 π Investigational Drug / Biologic
DAREONα΅α΄Ή-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard of Care Are Tolerated by People With Advanced Small Cell Lung Cancer
π Orlando Health Cancer Institute β Orlando, Florida
Small Cell Lung Carcinoma (SCLC)
View Study & Checklist β π’ Recruiting Phase2 π Investigational Drug / Biologic
DAREONβ’-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
π Infirmary Cancer Care β Mobile, Alabama
Small Cell Lung Carcinoma
View Study & Checklist β π’ Recruiting Phase1 π Investigational Drug / Biologic
A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3
π University of California Irvine β Orange, California
Glioma
View Study & Checklist β